Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutrition industries, has acquired the service unit of Exosomics, an extracellular vesicles biotech company.   The agreement includes Exosomics’ service team, service assets and laboratories in Siena, Italy. The financial details of the deal were not disclosed. Lonza has been a minority shareholder of Exosomics since 2017 and will remain a shareholder after the acquisition of the service unit is complete.   Under the ...